Sarah Parkinson is an analyst at RAND Europe working in the area of innovation, health and science research. Her work spans public health and healthcare, as well as looking at how research systems operate and ensure that they fund the best possible research.
Her recent and current work feature research at both a UK and European level, including a study for ECDC on the use of point of care testing devices for infectious diseases in EU/EEA member states and an evaluation of the Health Foundation's Q initiative. She has a M.Sc. in social policy and a B.A. in cultural anthropology from the University of Pennsylvania. Prior to joining RAND Europe, she worked in education policy and policies related to the opioid epidemic in Philadelphia.
Rodriguez-Rincon, D., Leach, B., Pollard, J., Parkinson, S., Gkousis, E., Lichten, C., Sussex, J., Manville, C., Exploring the societal burden of multiple sclerosis., RAND (RR-4262), 2019
Parks, S., Rodriguez-Rincon, D., Parkinson, S., Manville, C., The changing research landscape and reflections on national research assessment in the future, RAND (RR-3200), 2019
Parkinson, S., "Strengthening Prescription Drug Monitoring Program Mandates in the US," Public Sphere Journal of Public Policy (London School of Economics), 2018